Insights into the kinetics and dynamics of the furin-cleaved form of PCSK9-Reference-Cited by-同舟云学术

Insights into the kinetics and dynamics of the furin-cleaved form of PCSK9

Published:2021 Issue: Volume:62 Page:100003
ISSN:0022-2275
Container-title:Journal of Lipid Research
language:en
Short-container-title:Journal of Lipid Research

Author:

Oleaga Carlota^ORCID,Hay Joshua,Gurcan Emma,David Larry L.,Mueller Paul A.^ORCID,Tavori Hagai^ORCID,Shapiro Michael D.^ORCID,Pamir Nathalie^ORCID,Fazio Sergio^ORCID

Funder

National Institutes of Health

Publisher

Elsevier BV

Subject

Cell Biology,Endocrinology,Biochemistry

Reference55 articles.

1. Eradicating the burden of atherosclerotic cardiovascular disease by lowering apolipoprotein B lipoproteins earlier in life;Robinson;J. Am. Heart. Assoc.,2018

2. Novel therapeutic concepts: the epidemic of cardiovascular disease in the developing world: global implications;Gersh;Eur. Heart J.,2010

3. Recent trends in cardiovascular mortality in the United States and public health goals;Sidney;JAMA Cardiol.,2016

4. Regulation of the activity of the low density lipoprotein receptor in human fibroblasts;Brown;Cell,1975

5. Brown and Goldstein: the cholesterol chronicles;Nair;Proc. Natl. Acad. Sci. U. S. A.,2013

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Natural phytochemicals as small-molecule proprotein convertase subtilisin/kexin type 9 inhibitors;Tzu Chi Medical Journal;2024-09-05

2. The Role of Furin and Its Therapeutic Potential in Cardiovascular Disease Risk;International Journal of Molecular Sciences;2024-08-26

3. Effect of anti-PCSK9 drugs on the association of PCSK9 to LDL;European Atherosclerosis Journal;2024-04-30

4. Inclisiran—A Revolutionary Addition to a Cholesterol-Lowering Therapy;International Journal of Molecular Sciences;2023-04-06

5. PCSK9 is minimally associated with HDL but impairs the anti-atherosclerotic HDL effects on endothelial cell activation;Journal of Lipid Research;2022-10